Literature DB >> 20514494

Toxoplasma gondii: determinants of tachyzoite to bradyzoite conversion.

Sini Skariah1, Matthew Karmen McIntyre, Dana G Mordue.   

Abstract

Apicomplexa are primarily obligate intracellular protozoa that have evolved complex developmental stages important for pathogenesis and transmission. Toxoplasma gondii, responsible for the disease toxoplasmosis, has the broadest host range of the Apicomplexa as it infects virtually any warm-blooded vertebrate host. Key to T. gondii's pathogenesis is its ability to differentiate from a rapidly replicating tachyzoite stage during acute infection to a relatively non-immunogenic, dormant bradyzoite stage contained in tissue cysts. These bradyzoite cysts can reconvert back to tachyzoites years later causing serious pathology and death if a person becomes immune-compromised. Like the sexual stage sporozoites, bradyzoites are also orally infectious and a major contributor to transmission. Because of the critical role of stage conversion to pathogenesis and transmission, a major research focus is aimed at identifying molecular mediators and pathways that regulate differentiation. Tachyzoite to bradyzoite development can occur spontaneously in vitro and be induced in response to exogenous stress including but not limited to host immunity. The purpose of this review is to explore the potential contributors to stage differentiation in infection and how a determination is made by the parasite to differentiate from tachyzoites to bradyzoites.

Entities:  

Mesh:

Year:  2010        PMID: 20514494      PMCID: PMC3327608          DOI: 10.1007/s00436-010-1899-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  60 in total

1.  Toxoplasma gondii in primary rat CNS cells: differential contribution of neurons, astrocytes, and microglial cells for the intracerebral development and stage differentiation.

Authors:  C G Lüder; M Giraldo-Velásquez; M Sendtner; U Gross
Journal:  Exp Parasitol       Date:  1999-09       Impact factor: 2.011

2.  Cyclic nucleotide kinases and tachyzoite-bradyzoite transition in Toxoplasma gondii.

Authors:  Michael S Eaton; Louis M Weiss; Kami Kim
Journal:  Int J Parasitol       Date:  2005-09-22       Impact factor: 3.981

3.  Toxoplasma gondii Hsp90 is a potential drug target whose expression and subcellular localization are developmentally regulated.

Authors:  Pablo C Echeverria; Mariana Matrajt; Omar S Harb; María P Zappia; Monica A Costas; David S Roos; Jean François Dubremetz; Sergio O Angel
Journal:  J Mol Biol       Date:  2005-07-22       Impact factor: 5.469

Review 4.  Histone mediated gene activation in Toxoplasma gondii.

Authors:  William J Sullivan; Mohamed-Ali Hakimi
Journal:  Mol Biochem Parasitol       Date:  2006-04-18       Impact factor: 1.759

Review 5.  Macrophage nutriprive antimicrobial mechanisms.

Authors:  Rui Appelberg
Journal:  J Leukoc Biol       Date:  2006-04-07       Impact factor: 4.962

6.  Expression of Toxoplasma gondii-specific heat shock protein 70 during In vivo conversion of bradyzoites to tachyzoites.

Authors:  N M Silva; R T Gazzinelli; D A Silva; E A Ferro; L H Kasper; J R Mineo
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

7.  Inhibition of inducible nitric oxide synthase exacerbates chronic cerebral toxoplasmosis in Toxoplasma gondii-susceptible C57BL/6 mice but does not reactivate the latent disease in T. gondii-resistant BALB/c mice.

Authors:  D Schlüter; M Deckert-Schlüter; E Lorenz; T Meyer; M Röllinghoff; C Bogdan
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

8.  Isolation and characterization of a subtractive library enriched for developmentally regulated transcripts expressed during encystation of Toxoplasma gondii.

Authors:  B Yahiaoui; F Dzierszinski; A Bernigaud; C Slomianny; D Camus; S Tomavo
Journal:  Mol Biochem Parasitol       Date:  1999-04-30       Impact factor: 1.759

9.  Toxoplasma gondii bradyzoites form spontaneously during sporozoite-initiated development.

Authors:  M E Jerome; J R Radke; W Bohne; D S Roos; M W White
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  The transcriptome of Toxoplasma gondii.

Authors:  Jay R Radke; Michael S Behnke; Aaron J Mackey; Josh B Radke; David S Roos; Michael W White
Journal:  BMC Biol       Date:  2005-12-02       Impact factor: 7.431

View more
  42 in total

1.  Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.

Authors:  Wai Kit Chew; Ignacio Segarra; Stephen Ambu; Joon Wah Mak
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

Review 2.  The molecular biology and immune control of chronic Toxoplasma gondii infection.

Authors:  Xiao-Yu Zhao; Sarah E Ewald
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

3.  Reexamining Chronic Toxoplasma gondii Infection: Surprising Activity for a "Dormant" Parasite.

Authors:  Anthony P Sinai; Elizabeth A Watts; Animesh Dhara; Robert D Murphy; Matthew S Gentry; Abhijit Patwardhan
Journal:  Curr Clin Microbiol Rep       Date:  2016-10-04

4.  Toxoplasma gondii-positive human sera recognise intracellular tachyzoites and bradyzoites with diverse patterns of immunoreactivity.

Authors:  Marijo S Roiko; Kaice LaFavers; Diane Leland; Gustavo Arrizabalaga
Journal:  Int J Parasitol       Date:  2017-11-21       Impact factor: 3.981

5.  Novel Approaches To Kill Toxoplasma gondii by Exploiting the Uncontrolled Uptake of Unsaturated Fatty Acids and Vulnerability to Lipid Storage Inhibition of the Parasite.

Authors:  Sabrina J Nolan; Julia D Romano; John T Kline; Isabelle Coppens
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

6.  Inhibitors of eIF2α dephosphorylation slow replication and stabilize latency in Toxoplasma gondii.

Authors:  Christian Konrad; Sherry F Queener; Ronald C Wek; William J Sullivan
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

Review 7.  Human parasitic protozoan infection to infertility: a systematic review.

Authors:  Malihe Nourollahpour Shiadeh; Maryam Niyyati; Shirzad Fallahi; Ali Rostami
Journal:  Parasitol Res       Date:  2015-11-16       Impact factor: 2.289

Review 8.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

9.  Upregulated expression of Tim-3 involved in the process of toxoplasmic encephalitis in mouse model.

Authors:  Bin Wu; Bo Huang; Ying Chen; Shaoyuan Li; Junping Yan; Huanqin Zheng; Shiguang Huang; Jilong Shen; Zhao-Rong Lun; Yong Wang; Lloyd H Kasper; Fangli Lu
Journal:  Parasitol Res       Date:  2013-04-18       Impact factor: 2.289

10.  Otopathology in congenital toxoplasmosis.

Authors:  Mehti Salviz; Jose G Montoya; Joseph B Nadol; Felipe Santos
Journal:  Otol Neurotol       Date:  2013-08       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.